No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cell- and Tissue-Based Therapy
-
Humans
-
Lenalidomide / therapeutic use
-
Lymphoma, Large B-Cell, Diffuse* / drug therapy
-
Lymphoma, Large B-Cell, Diffuse* / pathology
-
Neoplasm Recurrence, Local / drug therapy
-
Receptors, Chimeric Antigen*
-
Rituximab / therapeutic use
Substances
-
Rituximab
-
Lenalidomide
-
Receptors, Chimeric Antigen
-
ibrutinib